Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000426522

Medchemexpress LLC Liraglutide TFA | 99.6% | 3751.20 | 5 MG
SDP

Catalog No. 5000426522
Encompass_Preferred

Liraglutide (TFA) is an agonist of the glucagon-like peptide 1 receptor (GLP-1). It can activate GLP-1, resulting in the release of insulin when glucose concentration is elevated. Additionally, Liraglutide (TFA) reduces glucagon secretion in a glucose-dependent manner and can be utilized in research concerning type 2 diabetes.

  • Agonist of glucagon-like peptide 1 receptor (GLP-1)
  • Activates GLP-1, which leads to insulin release in the presence of increased glucose concentration
  • Reduces glucagon secretion in a glucose-dependent manner
  • Can be studied in research on type 2 diabetes

Catalog No. 50-004-26522 Supplier Medchemexpress LLC Supplier No. HYP0014B5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Liraglutide (TFA) is an agonist of the glucagon-like peptide 1 receptor (GLP-1). It can activate GLP-1, resulting in the release of insulin when glucose concentration is elevated. Additionally, Liraglutide (TFA) reduces glucagon secretion in a glucose-dependent manner and can be utilized in research concerning type 2 diabetes.

  • Agonist of glucagon-like peptide 1 receptor (GLP-1)
  • Activates GLP-1, which leads to insulin release in the presence of increased glucose concentration
  • Reduces glucagon secretion in a glucose-dependent manner
  • Can be studied in research on type 2 diabetes

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.